CEPHEID had the largest decline in reported obligations
$35.9M→$17.5M−$18.4M
The contractor now ranks #2 by positive obligations and accounts for 23.7% of positive obligations, based on 167 reported actions.
Federal Capture Intelligence
Top VA in-vitro diagnostic substance manufacturing contractors (NAICS 325413)
Contract actions: October 1, 2021 – October 23, 2026
Updated October 24, 2026 Department of Veterans Affairs agency guide
NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
- Latest 12 months
- $70.5M
- Net obligations · Down $46.6M vs. $117.1M preceding
- Prime contractors
- 73
- With positive obligations in the latest 12 months
Research the VA federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, and contract types, competition, and procurement methods.
Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs
Federal records show $799.4M in net obligations across 3,957 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.23% of $349.8B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 39.8% from $117.1M to $70.5M. 10 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.
FY27 year-to-date: $18.1M versus $55.2M through the same date in FY26 (−67.2%).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $284.9M | 1,711 | Complete |
| FY2023 | $201.9M | 1,647 | Complete |
| FY2024 | $77.3M | 1,831 | Complete |
| FY2025 | $109.6M | 1,626 | Complete |
| FY2026 | $107.6M | 1,669 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $799.4M
- 3,957 awards · 172 prime contractors
- Latest 12-month movement
- −39.8%
- $70.5M vs. $117.1M
- Leading eight prime share
- 77.6%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.23% of $349.8B in agency-wide net obligations.
- Set-aside share when reported
- 16.7% of 1,537 awards with reported set-aside status.
- Set-aside reporting
- 257 set aside · 1,280 no set-aside · 2,420 not reported
What changed in the last 12 months?
Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.
Competitive shifts
BECKMAN COULTER, INC climbed the most in the contractor rankings
#39→#7Up 32 places
The contractor accounts for 1.7% of positive obligations across 29 reported actions.
ONE LAMBDA, INC. fell the most in the contractor rankings
#14→#67Down 53 places
The contractor accounts for 0.030% of positive obligations across 1 reported action.
ROCHE DIAGNOSTICS CORPORATION gained the most market share
7.0%→12.4%+5.4 percentage points
The contractor now ranks #3 by positive obligations, based on 178 reported actions.
Buyer demand
Reported obligations through 664-SAN DIEGO HEALTHCARE SYS(00664) decreased
$6.2M→$1.8M−$4.3M
Latest-period activity spans 20 awards across 10 prime contractors.
Reported obligations through 674-TEMPLE (00674) increased
$694K→$3.2M+$2.5M
Latest-period activity spans 17 awards across 10 prime contractors.
View 1 additional material change
Competitive shifts
HOLOGIC, INC. recorded the largest net deobligation
$825K→−$1.0M−$1.8M
The contractor now is unranked by positive obligations, based on 10 reported actions.
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.
7.5% of positive obligations were attributed to 691-VA GREATER LA HLTHCR SYS(00691). That represents $5.7M, up $450K from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- 691-VA GREATER LA HLTHCR SYS(00691)7.5% · $5.7M · up $450K
- 241-NETWORK CONTRACT OFFICE 01 (36C241)5.8% · $4.4M · up $986K
- 248-NETWORK CONTRACT OFFICE 8 (36C248)5.7% · $4.3M · down $1.5M
- 644-PHOENIX (00644)5.4% · $4.1M · down $398K
- 674-TEMPLE (00674)4.2% · $3.2M · up $2.5M
- All other reported offices71.4% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
691-VA GREATER LA HLTHCR SYS(00691)
#1Up 2 from #3Latest 12 months
$5.7M
7.5% of positive obligations
Versus preceding 12 months
+$450K
22 active prime contractors · 44 awards
View office comparison and evidence
Reported obligations increased 8.5% from $5.3M to $5.7M. The office’s share of positive obligations moved from 4.4% to 7.5%, a change of +3.2 percentage points.
The latest period contains 61 actions across 44 awards and 5 newly active prime contractors. The preceding period contained 18 active prime contractors and 28 awards.
Reported funding office
241-NETWORK CONTRACT OFFICE 01 (36C241)
#2Up 7 from #9Latest 12 months
$4.4M
5.8% of positive obligations
Versus preceding 12 months
+$986K
17 active prime contractors · 37 awards
View office comparison and evidence
Reported obligations increased 28.7% from $3.4M to $4.4M. The office’s share of positive obligations moved from 2.8% to 5.8%, a change of +3.0 percentage points.
The latest period contains 55 actions across 37 awards and 8 newly active prime contractors. The preceding period contained 14 active prime contractors and 32 awards.
Reported funding office
248-NETWORK CONTRACT OFFICE 8 (36C248)
#3Down 1 from #2Latest 12 months
$4.3M
5.7% of positive obligations
Versus preceding 12 months
−$1.5M
3 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations decreased 26.2% from $5.8M to $4.3M. The office’s share of positive obligations moved from 4.8% to 5.7%, a change of +0.9 percentage points.
The latest period contains 15 actions across 12 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 15 awards.
Reported funding office
644-PHOENIX (00644)
#4Up 2 from #6Latest 12 months
$4.1M
5.4% of positive obligations
Versus preceding 12 months
−$398K
5 active prime contractors · 20 awards
View office comparison and evidence
Reported obligations decreased 8.8% from $4.5M to $4.1M. The office’s share of positive obligations moved from 3.7% to 5.4%, a change of +1.7 percentage points.
The latest period contains 31 actions across 20 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 13 awards.
Reported funding office
674-TEMPLE (00674)
#5Up 48 from #53Latest 12 months
$3.2M
4.2% of positive obligations
Versus preceding 12 months
+$2.5M
10 active prime contractors · 17 awards
View office comparison and evidence
Reported obligations increased 357.4% from $694K to $3.2M. The office’s share of positive obligations moved from 0.57% to 4.2%, a change of +3.6 percentage points.
The latest period contains 31 actions across 17 awards and 1 newly active prime contractor. The preceding period contained 11 active prime contractors and 18 awards.
Leading award-level changes
- CEPHEID · PIID 36C25726N0164+$1.6M: $0 → $1.6M
- ROCHE DIAGNOSTICS CORPORATION · PIID 36C25722C0025+$783K: −$574K → $210K
Reported funding office
261-NETWORK CONTRACT OFFICE 21 (36C261)
#6Up 1 from #7Latest 12 months
$3.1M
4.1% of positive obligations
Versus preceding 12 months
−$1.3M
5 active prime contractors · 20 awards
View office comparison and evidence
Reported obligations decreased 28.5% from $4.4M to $3.1M. The office’s share of positive obligations moved from 3.6% to 4.1%, a change of +0.5 percentage points.
The latest period contains 21 actions across 20 awards and 1 newly active prime contractor. The preceding period contained 9 active prime contractors and 38 awards.
Reported funding office
663-SEATTLE (00663)
#7Up 43 from #50Latest 12 months
$2.7M
3.6% of positive obligations
Versus preceding 12 months
+$2.0M
9 active prime contractors · 16 awards
View office comparison and evidence
Reported obligations increased 252.5% from $776K to $2.7M. The office’s share of positive obligations moved from 0.64% to 3.6%, a change of +3.0 percentage points.
The latest period contains 24 actions across 16 awards and 3 newly active prime contractors. The preceding period contained 7 active prime contractors and 11 awards.
Reported funding office
HAMPTON 590 (36C590)
#8Up 18 from #26Latest 12 months
$2.7M
3.5% of positive obligations
Versus preceding 12 months
+$1.2M
4 active prime contractors · 13 awards
View office comparison and evidence
Reported obligations increased 80.5% from $1.5M to $2.7M. The office’s share of positive obligations moved from 1.2% to 3.5%, a change of +2.3 percentage points.
The latest period contains 18 actions across 13 awards. The preceding period contained 7 active prime contractors and 18 awards.
Reported funding office
VETERANS HEALTH ADMINISTRATION
#9Down 4 from #5Latest 12 months
$2.4M
3.1% of positive obligations
Versus preceding 12 months
−$2.3M
8 active prime contractors · 37 awards
View office comparison and evidence
Reported obligations decreased 49.4% from $4.7M to $2.4M. The office’s share of positive obligations moved from 3.9% to 3.1%, a change of −0.8 percentage points.
The latest period contains 43 actions across 37 awards and 1 newly active prime contractor. The preceding period contained 8 active prime contractors and 26 awards.
Reported funding office
600-VA LONG BEACH HLTCAR SYS(00600)
#10Down 2 from #8Latest 12 months
$2.4M
3.1% of positive obligations
Versus preceding 12 months
−$1.5M
8 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations decreased 38.0% from $3.8M to $2.4M. The office’s share of positive obligations moved from 3.1% to 3.1%, a change of 0.0 percentage points.
The latest period contains 15 actions across 12 awards and 2 newly active prime contractors. The preceding period contained 8 active prime contractors and 9 awards.
Reported funding office
541-BRECKSVILLE (00541)
#11Up 45 from #56Latest 12 months
$2.0M
2.6% of positive obligations
Versus preceding 12 months
+$1.4M
6 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 224.4% from $604K to $2.0M. The office’s share of positive obligations moved from 0.50% to 2.6%, a change of +2.1 percentage points.
The latest period contains 10 actions across 8 awards and 4 newly active prime contractors. The preceding period contained 5 active prime contractors and 6 awards.
Reported funding office
664-SAN DIEGO HEALTHCARE SYS(00664)
#12Down 11 from #1Latest 12 months
$1.8M
2.4% of positive obligations
Versus preceding 12 months
−$4.3M
10 active prime contractors · 20 awards
View office comparison and evidence
Reported obligations decreased 70.6% from $6.2M to $1.8M. The office’s share of positive obligations moved from 5.1% to 2.4%, a change of −2.7 percentage points.
The latest period contains 28 actions across 20 awards and 2 newly active prime contractors. The preceding period contained 10 active prime contractors and 16 awards.
Reported funding office
689-WEST HAVEN (00689)(36C689)
No positive-obligation rankLatest 12 months
−$120K
0% of positive obligations
Versus preceding 12 months
+$1.1M
8 active prime contractors · 10 awards
View office comparison and evidence
Reported obligations narrowed from $1.2M to $120K in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 10 actions across 10 awards and 1 newly active prime contractor. The preceding period contained 9 active prime contractors and 16 awards.
Reported funding office
244-NETWORK CONTRACT OFFICE 4 (36C244)
No positive-obligation rankLatest 12 months
−$383K
0% of positive obligations
Versus preceding 12 months
−$2.7M
3 active prime contractors · 19 awards
View office comparison and evidence
Reported obligations moved from $2.4M in net obligations to $383K in net deobligations. The office’s share of positive obligations moved from 1.9% to 0%, a change of −1.9 percentage points.
The latest period contains 26 actions across 19 awards and 1 newly active prime contractor. The preceding period contained 3 active prime contractors and 23 awards.
Reported funding office
618-MINNEAPOLIS VA MED CTR (00618)
No positive-obligation rankLatest 12 months
−$406K
0% of positive obligations
Versus preceding 12 months
−$2.9M
16 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations moved from $2.5M in net obligations to $406K in net deobligations. The office’s share of positive obligations moved from 2.0% to 0%, a change of −2.0 percentage points.
The latest period contains 30 actions across 23 awards and 1 newly active prime contractor. The preceding period contained 19 active prime contractors and 45 awards.
Reported funding office
589 KAN WESTERN ORBIT
No positive-obligation rankLatest 12 months
−$642K
0% of positive obligations
Versus preceding 12 months
−$5.8M
14 active prime contractors · 35 awards
View office comparison and evidence
Reported obligations moved from $5.2M in net obligations to $642K in net deobligations. The office’s share of positive obligations moved from 4.3% to 0%, a change of −4.3 percentage points.
The latest period contains 65 actions across 35 awards and 2 newly active prime contractors. The preceding period contained 16 active prime contractors and 32 awards.
Leading award-level changes
- CEPHEID · PIID 36C25525N0329−$4.4M: $2.9M → −$1.5M
- CEPHEID · PIID 36C25524N0348−$3.0M: $1.9M → −$1.1M
Reported funding office
626-NASHVILLE (00626)
No positive-obligation rankLatest 12 months
−$950K
0% of positive obligations
Versus preceding 12 months
−$2.6M
5 active prime contractors · 6 awards
View office comparison and evidence
Reported obligations moved from $1.7M in net obligations to $950K in net deobligations. The office’s share of positive obligations moved from 1.4% to 0%, a change of −1.4 percentage points.
The latest period contains 6 actions across 6 awards. The preceding period contained 8 active prime contractors and 13 awards.
Contract types, competition, and procurement methods
From Oct 24, 2025 through Oct 23, 2026, 572 awards had positive obligations totaling $102.3M. Simplified Acquisition was the leading reported procedure, accounting for 22.8% of positive obligations. Awards with a reported parent IDV accounted for 77.8%.
- Leading award type
- 43.5%
- Delivery Order
- Leading reported procedure
- 22.8%
- Simplified Acquisition
- Reported parent IDV
- 77.8%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 287 of 572 awards reported offers
Buying method changes
Compared with Oct 24, 2024–Oct 23, 2025. Based on 572 current awards and 792 preceding awards with positive net obligations.
- Simplified Acquisition obligation share
- 22.8%
- Down from 41.7% in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325413 peer median, parent-IDV obligation share is 17.4 percentage points higher, reported full-and-open obligation share is 2.9 percentage points higher, delivery-order obligation share is 14.1 percentage points higher, and median positive award obligations are 43.3% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 77.8% | 60.5% | +17.4 pts |
| Reported full-and-open obligation share | 12.9% | 10.0% | +2.9 pts |
| Delivery-order obligation share | 43.5% | 29.4% | +14.1 pts |
| Median positive award obligations | $69K | $48K | +43.3% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Defense (DOD)
- Department of Health and Human Services (HHS)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 249 | $44.5M | 43.5% |
| BPA Call(A) | 198 | $35.1M | 34.3% |
| Purchase Order(B) | 114 | $21.0M | 20.6% |
| Definitive Contract(D) | 11 | $1.6M | 1.6% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 204 | $38.1M | 37.3% |
| BPA(E) | 198 | $35.1M | 34.3% |
| FSS(C) | 45 | $6.4M | 6.3% |
| Not reported | 125 | $22.7M | 22.2% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 378 | $72.7M | 71.0% |
| Multiple Award(M) | 69 | $7.0M | 6.8% |
| Not reported | 125 | $22.7M | 22.2% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Simplified Acquisition(SP1) | 162 | $23.3M | 22.8% |
| Only One Source(SSS) | 81 | $21.5M | 21.0% |
| Sp1(SIMPLIFIED ACQUISITION) | 111 | $15.3M | 14.9% |
| Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY) | 71 | $13.6M | 13.3% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 86 | $10.8M | 10.5% |
| Sss(ONLY ONE SOURCE) | 38 | $9.5M | 9.3% |
| Other reported values | 23 | $8.4M | 8.2% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not Competed(C) | 80 | $21.1M | 20.6% |
| A(FULL AND OPEN COMPETITION) | 83 | $19.2M | 18.7% |
| Full and Open Competition(A) | 93 | $13.2M | 12.9% |
| Not Competed Under SAP(G) | 60 | $12.6M | 12.3% |
| Competed Under SAP(F) | 104 | $10.8M | 10.5% |
| F(COMPETED UNDER SAP) | 72 | $10.4M | 10.2% |
| Other reported values | 80 | $15.0M | 14.7% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Fair Opportunity Given(FAIR) | 90 | $13.6M | 13.3% |
| Only One Source - Other(ONE) | 59 | $10.0M | 9.8% |
| Follow-on Action Following Competitive Initial Action(FOO) | 3 | $620K | 0.61% |
| Competitive Set Aside(CSA) | 3 | $88K | 0.090% |
| Other Statutory Authority(OSA) | 1 | $59K | 0.060% |
| Sole Source(SS) | 1 | $38K | 0.040% |
| Not reported | 415 | $78.0M | 76.2% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 99 | $24.9M | 24.3% |
| SAP Non-Competition (FAR 13)(SP2) | 89 | $14.4M | 14.0% |
| Urgency (FAR 6.302-2)(URG) | 10 | $4.9M | 4.8% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 11 | $3.4M | 3.4% |
| Brand Name Description (FAR 6.302-1(C))(BND) | 4 | $537K | 0.52% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 4 | $275K | 0.27% |
| Other reported values | 1 | $54K | 0.053% |
| Not reported | 354 | $53.9M | 52.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 339 | $58.3M | 57.0% |
| J(FIRM FIXED PRICE) | 233 | $44.0M | 43.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 362 | $70.6M | 69.0% |
| Laboratory Equipment and Supplies(6640) | 114 | $18.3M | 17.9% |
| Reference Laboratory Testing(Q301) | 26 | $7.7M | 7.5% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 33 | $4.0M | 3.9% |
| Optical Instruments, Test Equipment, Components and Accessories(6650) | 4 | $512K | 0.50% |
| Chemical Analysis Instruments(6630) | 6 | $404K | 0.39% |
| Other reported values | 27 | $841K | 0.82% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 572 | $102.3M | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 262-Network Contract Office 22 (36c262)(36C262) | 100 | $19.9M | 19.4% |
| 246-Network Contracting Office 6 (36c246)(36C246) | 59 | $11.9M | 11.7% |
| 257-Network Contract Office 17 (36c257)(36C257) | 49 | $11.5M | 11.3% |
| 248-Network Contract Office 8 (36c248)(36C248) | 20 | $7.9M | 7.7% |
| 241-Network Contract Office 01 (36c241)(36C241) | 51 | $6.8M | 6.6% |
| 260-Network Contract Office 20 (36c260)(36C260) | 40 | $5.9M | 5.7% |
| Other reported values | 253 | $38.5M | 37.6% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36C24626D0001(3600) | 15 | $6.4M | 6.3% |
| 36C24825D0014(3600) | 7 | $5.7M | 5.6% |
| 36C25726D0032(3600) | 2 | $3.1M | 3.1% |
| 36C25225A0002(3600) | 9 | $2.7M | 2.7% |
| 36C25524A0028(3600) | 1 | $2.6M | 2.5% |
| 36C24625A0011(3600) | 11 | $2.4M | 2.4% |
| 36C24926D0023(3600) | 5 | $2.1M | 2.1% |
| 36F79724D0201(3600) | 2 | $2.0M | 2.0% |
| Other reported values | 395 | $52.4M | 51.2% |
| Not reported | 125 | $22.7M | 22.2% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 287 reported · 285 not reported
- Positive award obligations
- $69K median
- $27K–$192K middle 50%
- Reported performance period
- 364 days (~12 months) median
- 571 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 10 of 73prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 27.0%of positive obligations in the last 12 months
- Leading four prime contractors
- 69.1%of positive obligations in the last 12 months
- Leading eight prime contractors
- 77.6%of positive obligations in the last 12 months
Based on $73.7M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
15 leading contractors
- #1
Last 12mo obligations
$19.9M
27.0%
Dollar movement
−$12.2M
vs. prior 12 months
Last 12mo awards
184 awards
222 actions
Historical and award details for BIOMERIEUX INC
- Obligations: prior → latest
- $32.0M → $19.9M
- −38.0%
- Share: prior → latest
- 26.8% → 27.0%
- +0.2 percentage points
- All-period obligations
- $84.2M
- 10.5% of all-period positive obligations · 418 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 23 31 Not reported 161 160 Reported small business 2 3 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$17.5M
23.7%
Dollar movement
−$18.4M
vs. prior 12 months
Last 12mo awards
117 awards
167 actions
Historical and award details for CEPHEID
- Obligations: prior → latest
- $35.9M → $17.5M
- −51.3%
- Share: prior → latest
- 30.0% → 23.7%
- −6.3 percentage points
- All-period obligations
- $292.5M
- 36.5% of all-period positive obligations · 368 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 22 26 Not reported 95 114 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$9.1M
12.4%
Dollar movement
+$752K
vs. prior 12 months
Last 12mo awards
138 awards
178 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- $8.4M → $9.1M
- +9.0%
- Share: prior → latest
- 7.0% → 12.4%
- +5.4 percentage points
- All-period obligations
- $51.7M
- 6.5% of all-period positive obligations · 448 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 50 44 Not reported 88 111 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$4.4M
6.0%
Dollar movement
+$98K
vs. prior 12 months
Last 12mo awards
8 awards
15 actions
Historical and award details for QUEST DIAGNOSTICS INCORPORATED
- Obligations: prior → latest
- $4.3M → $4.4M
- +2.3%
- Share: prior → latest
- 3.6% → 6.0%
- +2.4 percentage points
- All-period obligations
- $8.8M
- 1.1% of all-period positive obligations · 9 awards
- Recorded activity
- Since Feb 1, 2023
- through Sep 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 8 8 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$2.5M
3.3%
Dollar movement
−$509K
vs. prior 12 months
Last 12mo awards
48 awards
82 actions
Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
- Obligations: prior → latest
- $3.0M → $2.5M
- −17.1%
- Share: prior → latest
- 2.5% → 3.3%
- +0.9 percentage points
- All-period obligations
- $14.8M
- 1.8% of all-period positive obligations · 138 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 9 Not reported 35 39 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.4M
1.9%
Dollar movement
+$409K
vs. prior 12 months
Last 12mo awards
19 awards
27 actions
Historical and award details for ABBOTT MOLECULAR INC.
- Obligations: prior → latest
- $1.0M → $1.4M
- +40.2%
- Share: prior → latest
- 0.85% → 1.9%
- +1.1 percentage points
- All-period obligations
- $18.4M
- 2.3% of all-period positive obligations · 84 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 7, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 5 6 Not reported 14 16 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$1.3M
1.7%
Dollar movement
+$1.0M
vs. prior 12 months
Last 12mo awards
21 awards
29 actions
Historical and award details for BECKMAN COULTER, INC
- Obligations: prior → latest
- $280K → $1.3M
- +357.9%
- Share: prior → latest
- 0.23% → 1.7%
- +1.5 percentage points
- All-period obligations
- $7.6M
- 0.94% of all-period positive obligations · 84 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 19 Not reported 6 8 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$1.1M
1.5%
Dollar movement
−$388K
vs. prior 12 months
Last 12mo awards
12 awards
14 actions
Historical and award details for BECTON, DICKINSON AND COMPANY
- Obligations: prior → latest
- $1.5M → $1.1M
- −25.5%
- Share: prior → latest
- 1.3% → 1.5%
- +0.3 percentage points
- All-period obligations
- $4.4M
- 0.54% of all-period positive obligations · 43 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 18, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 8 11 Not reported 4 3 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.1M
1.5%
Dollar movement
+$169K
vs. prior 12 months
Last 12mo awards
13 awards
16 actions
Historical and award details for BINDING SITE, INC., THE
- Obligations: prior → latest
- $964K → $1.1M
- +17.5%
- Share: prior → latest
- 0.81% → 1.5%
- +0.7 percentage points
- All-period obligations
- $5.2M
- 0.65% of all-period positive obligations · 35 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 13, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 1 Reported no set-aside 8 8 Not reported 5 5 Reported small business 13 13 All-period set-aside types
- 1 · Total small business
- #10
Last 12mo obligations
$1.1M
1.5%
Dollar movement
−$1.4M
vs. prior 12 months
Last 12mo awards
82 awards
107 actions
Historical and award details for WERFEN USA LLC
- Obligations: prior → latest
- $2.5M → $1.1M
- −54.8%
- Share: prior → latest
- 2.1% → 1.5%
- −0.6 percentage points
- All-period obligations
- $5.4M
- 0.67% of all-period positive obligations · 143 awards
- Recorded activity
- Since Oct 27, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 5 Not reported 67 76 Reported small business 16 16 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$972K
1.3%
Dollar movement
−$124K
vs. prior 12 months
Last 12mo awards
13 awards
17 actions
Historical and award details for QIAGEN, LLC
- Obligations: prior → latest
- $1.1M → $972K
- −11.3%
- Share: prior → latest
- 0.92% → 1.3%
- +0.4 percentage points
- All-period obligations
- $4.7M
- 0.58% of all-period positive obligations · 33 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 8, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 12 8 Not reported 1 3 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$908K
1.2%
Dollar movement
+$458K
vs. prior 12 months
Last 12mo awards
1 award
5 actions
Historical and award details for CYTOPATH BIOPSY LAB INC
- Obligations: prior → latest
- $450K → $908K
- +101.8%
- Share: prior → latest
- 0.38% → 1.2%
- +0.8 percentage points
- All-period obligations
- $2.3M
- 0.28% of all-period positive obligations · 1 award
- Recorded activity
- Since Oct 12, 2023
- through Oct 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$892K
1.2%
Dollar movement
+$288K
vs. prior 12 months
Last 12mo awards
33 awards
43 actions
Historical and award details for HOLOGIC SALES AND SERVICE, LLC
- Obligations: prior → latest
- $604K → $892K
- +47.7%
- Share: prior → latest
- 0.50% → 1.2%
- +0.7 percentage points
- All-period obligations
- $8.6M
- 1.1% of all-period positive obligations · 103 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 17 18 Not reported 16 17 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$853K
1.2%
Dollar movement
+$392K
vs. prior 12 months
Last 12mo awards
5 awards
9 actions
Historical and award details for 10X GENOMICS, INC.
- Obligations: prior → latest
- $461K → $853K
- +84.9%
- Share: prior → latest
- 0.39% → 1.2%
- +0.8 percentage points
- All-period obligations
- $1.4M
- 0.18% of all-period positive obligations · 11 awards
- Recorded activity
- Since Jun 3, 2024
- through Oct 19, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 5 3 Not reported 0 0 Reported small business 2 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$846K
1.1%
Dollar movement
−$33K
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for DIAGNOSTICA STAGO INC
- Obligations: prior → latest
- $879K → $846K
- −3.8%
- Share: prior → latest
- 0.73% → 1.1%
- +0.4 percentage points
- All-period obligations
- $2.8M
- 0.35% of all-period positive obligations · 5 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
Base award
This action
+$1.6M
CEPHEID
674-TEMPLE (00674)
CEPHEID REAGENTS CONTRACT - ORDERING PERIOD 1
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 2.1% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $18.4M overall.
- Award net obligations
- $1.6M
- Share of 12-month positive obligations
- 2.1%
Supporting data
- Prime contractor
- #2 · 23.7% share
- $18.4M net decline despite this positive action
- Funding office
- #5 · 4.2% attributed share
- up 48 ranks · +3.6 percentage points · $2.5M net increase; action accounted for 63.0%
Related:Funding office gain
Base award
This action
+$2.6M
CEPHEID
589 KAN WESTERN ORBIT
IN-VITRO REAGENTS - VISN 15, ORDERING PERIOD TWO
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 3.5% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $18.4M overall.
- Award net obligations
- $2.6M
- Share of 12-month positive obligations
- 3.5%
Supporting data
- Prime contractor
- #2 · 23.7% share
- $18.4M net decline despite this positive action
- Funding office
- 0% attributed share
- $5.8M net decline despite this positive action
Base award
This action
+$2.5M
BIOMERIEUX INC
248-NETWORK CONTRACT OFFICE 8 (36C248)
MOLECULAR PATHOGEN DETECTION
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 3.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $12.2M overall.
- Award net obligations
- $2.5M
- Share of 12-month positive obligations
- 3.4%
Supporting data
- Prime contractor
- #1 · 27.0% share
- $12.2M net decline despite this positive action
- Funding office
- #3 · 5.7% attributed share
- $1.5M net decline despite this positive action
Deobligation
This action
−$637K
HOLOGIC, INC.
626-NASHVILLE (00626)
MICROBIOLOGY TEST ASSAY, KITS, SUPPLIES CLIN CORRECTION DECREASE FOR FINAL OBLIGATION
Why it stands out
This award recorded a material contraction.
The action removed $637K. A deobligation does not by itself show lower requirement demand.
- Award net obligations
- $203K
- Share of 12-month positive obligations
- 0.86%
Supporting data
- Prime contractor
- 0% share
- −0.7 percentage points · $1.8M net decline; action accounted for 34.9%
- Funding office
- 0% attributed share
- −1.4 percentage points · $2.6M net decline; action accounted for 24.3%
Related:Largest net deobligation
Base award
This action
+$1.5M
ABBOTT MOLECULAR INC.
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS
ALINITY M ORDER
Why it stands out
The contractor climbed 13 positions in this market.
It now ranks #6 by positive obligations over the latest 12 months.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 2.0%
Supporting data
- Funding office
- #22 · 1.4% attributed share
- $651K net decline despite this positive action
Base award
This action
+$1.2M
ROCHE DIAGNOSTICS CORPORATION
648-PORTLAND (00648)
CHEMISTRY IMMUNOCHEMISTRY INSTRUMENTATION REAGENTS, CONSUMABLES AND SUPPLIES FOR VA PORTLAND HEALTH CARE SYSTEM.
Why it stands out
The funding office climbed 4 positions in attributed spending.
It now ranks #14 in attributed spending.
- Award net obligations
- $700K
- Share of 12-month positive obligations
- 1.6%
Supporting data
- Funding office
- #14 · 2.2% attributed share
- $147K net decline despite this positive action
View recent award activity by date (10)
- Action−$1.5MAward net obligations$1.4M
- Action+$98KAward net obligations$98K
- Action+$44KAward net obligations$162K
- Action+$31KAward net obligations$31K
- Action−$11KAward net obligations$194K
- Action−$7KAward net obligations$50K
- Action−$288Award net obligations$61K
- Action+$282Award net obligations$10K
- Action+$66KAward net obligations$66K
- Action+$43KAward net obligations$43K
VA in-vitro diagnostic substance manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top VA in-vitro diagnostic substance manufacturing contractors?
In the 12 months through October 23, 2026, BIOMERIEUX INC, CEPHEID, and ROCHE DIAGNOSTICS CORPORATION were the leading VA in-vitro diagnostic substance manufacturing prime contractors by positive obligations.
- #1
$19,854,203 in positive obligations
- #2
$17,471,475 in positive obligations
- #3
$9,149,468 in positive obligations
Rankings use reported USAspending award data.
Did VA contract obligations decrease in the in-vitro diagnostic substance manufacturing market?
Yes. Measured by net prime contract obligations, reported VA activity in the in-vitro diagnostic substance manufacturing market decreased 39.8% from $117,062,350 in the preceding 12 months to $70,496,704 in the 12 months through October 23, 2026.
- Latest 12 months
- $70,496,704
- Net prime contract obligations
- Preceding 12 months
- $117,062,350
- Net prime contract obligations
- Change
- −39.8%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent VA contract award activity was reported in the in-vitro diagnostic substance manufacturing market?
Recent VA contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for CEPHEID, BIOMERIEUX INC, and HOLOGIC, INC. during the 12 months through October 23, 2026.
-
CEPHEID · PIID 36C25726N0164
Base award · December 19, 2025 · Action obligation: +$1,564,125
-
CEPHEID · PIID 36C25526N0337
Base award · July 28, 2026 · Action obligation: +$2,571,141
-
BIOMERIEUX INC · PIID 36C24826N0280
Base award · January 13, 2026 · Action obligation: +$2,471,720
-
HOLOGIC, INC. · PIID 36C24925N0069
Deobligation P00001 · March 25, 2026 · Action obligation: -$636,610
-
ABBOTT MOLECULAR INC. · PIID 36C24226N0439
Base award · May 4, 2026 · Action obligation: +$1,481,077
-
ROCHE DIAGNOSTICS CORPORATION · PIID 36C26026N0117
Base award · February 4, 2026 · Action obligation: +$1,200,000
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for VA contracts under NAICS 325413?
From October 24, 2025 through October 23, 2026, VA reported 572 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was delivery order. The leading reported procedure was simplified acquisition.
- Positive-obligation awards
- 572
- Leading reported procedure
- Simplified Acquisition
- 22.8% of positive obligations
- Leading award type
- Delivery Order
- 43.5% of positive obligations
- Full and open
- 12.9%
- of positive obligations
- Reported parent IDV
- 77.8%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology